Avita Medical Inc. (RCEL) vs Sanara MedTech Inc. (SMTI)

A side-by-side comparison of Avita Medical Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — RCEL vs SMTI

growth of $100 · dividends reinvested · last 10y
RCEL +44.8% (+3.8%/yr)SMTI +775.0% (+24.2%/yr)SMTI compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$145$875
RCEL SMTI

RCEL vs SMTI: by the numbers

  • •SMTI is the larger company ($322M vs $321M market cap).
  • •Both run net losses; SMTI's is the smaller (-29.15% vs -56.96% net margin).
  • •SMTI grew revenue faster over the past five years (40.06% vs 20.94% CAGR).

Metrics side by side

Valuation

MetricRCELSMTI
Forward P/EN/A184.13
P/S ratio4.252.93
P/B ratioN/A40.49
EV / EBITDAN/A27.79
FCF yieldN/A1.40%

Profitability

MetricRCELSMTI
Gross margin81.56%91.33%
Operating margin-59.40%9.36%
Net margin-56.96%-29.15%
ROEN/A-403.03%
ROIC-136.92%18.15%

Growth (annualized)

MetricRCELSMTI
Revenue CAGR (5Y)20.94%40.06%
Total return CAGR (5Y)-5.28%0.35%

Frequently asked

Which has grown faster, RCEL or SMTI?
Over the past five years, SMTI grew revenue faster — RCEL at a 20.94% CAGR versus SMTI at 40.06%.
How have RCEL and SMTI total returns compared?
Over the past 10 years, RCEL delivered 4.36% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.